Is a complete IMVT research report available?

No complete published report is available for Immunovant, Inc. (IMVT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Immunovant, Inc. (IMVT)

NASDAQ: IMVT · USD

$29.4

+0.55 (+1.9%)· Recorded snapshot

Market cap	6.1B
Net income (ttm)	-538.2M
EPS (ttm)	-$2.82
Shares out	206.6M
Volume	1,007,127
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -538.2M
EPS (ttm): -$2.82
Market cap: 6.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001764013
Company name	Immunovant, Inc.
Country	United States
Country code	US
CUSIP number	45258J102
Earnings date	2026-11-09
Earnings time	bmo
Employees	315
Employees change	-47
Employees growth	-12.98%
Enterprise value	$5.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US45258J1025
Last 10-K release date	2026-05-20
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.43
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	IMVT
U.S. state	North Carolina
Website	https://immunovant.com

Metric

Value

Amount currency

USD

CIK code

0001764013

Company name

Immunovant, Inc.

Country

United States

Country code

CUSIP number

45258J102

Earnings date

2026-11-09

Earnings time

bmo

Employees

315

Employees change

-47

Employees growth

-12.98%

Enterprise value

$5.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

March

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US45258J1025

Last 10-K release date

2026-05-20

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$6.1B

Market cap category

Mid-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$29.43

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

IMVT

U.S. state

North Carolina

Website

https://immunovant.com

Metric	Value
Earnings yield	-9.57%
FCF / EV yield	-7.94%
FCF yield	-6.89%
P/B ratio	8.1x
Price / tangible book value	8.18x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-9.57%

FCF / EV yield

-7.94%

FCF yield

-6.89%

P/B ratio

8.1x

Price / tangible book value

8.18x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.7M
ROA	-46.73%
ROA (5Y)	-31.43%
ROCE	-76.97%
ROE	-80.1%
ROE (5Y)	-53.46%
ROIC	-52.64%

Metric

Value

Profit per employee

$-1.7M

ROA

-46.73%

ROA (5Y)

-31.43%

ROCE

-76.97%

ROE

-80.1%

ROE (5Y)

-53.46%

ROIC

-52.64%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-8,000
Depreciation and amortization	$394,000
EBIT	$-566M
EBITDA	$-565.6M
EPS	$-2.82
FCF per share	$-2.01
Financing cash flow	$612.9M
Free cash flow	$-414.3M
Free cash flow minus SBC	$-465.3M
Income taxes	$-698,000
Investing cash flow	$-8,000
Net cash flow	$198.9M
Net income	$-538.2M
Operating cash flow minus SBC	$-465.3M
Operating income	$-566M
Stock-based compensation	$51M

Metric

Value

Capital expenditures

$-8,000

Depreciation and amortization

$394,000

EBIT

$-566M

EBITDA

$-565.6M

EPS

$-2.82

FCF per share

$-2.01

Financing cash flow

$612.9M

Free cash flow

$-414.3M

Free cash flow minus SBC

$-465.3M

Income taxes

$-698,000

Investing cash flow

$-8,000

Net cash flow

$198.9M

Net income

$-538.2M

Operating cash flow minus SBC

$-465.3M

Operating income

$-566M

Stock-based compensation

$51M

Metric	Value
Book value per share	$3.57
Debt / equity	0
Long-term assets	$1.3M
Long-term liabilities	$0
Net cash (debt)	$797.8M
Net cash / market cap	13.26%
Net cash growth	33.21%
Net debt / equity	-1.08
Piotroski F-Score	1
Property, plant and equipment	$351,000
Shareholders' equity	$735.4M
Tangible book value	$735.4M
Tangible book value per share	$3.57
Total assets	$852.5M
Total cash	$797.8M
Total debt	$0
Total liabilities	$117.1M
WACC	8.87%

Metric

Value

Book value per share

$3.57

Debt / equity

Long-term assets

$1.3M

Long-term liabilities

Net cash (debt)

$797.8M

Net cash / market cap

13.26%

Net cash growth

33.21%

Net debt / equity

-1.08

Piotroski F-Score

Property, plant and equipment

$351,000

Shareholders' equity

$735.4M

Tangible book value

$735.4M

Tangible book value per share

$3.57

Total assets

$852.5M

Total cash

$797.8M

Total debt

Total liabilities

$117.1M

WACC

8.87%

Metric	Value
Current assets	$851.2M
Current liabilities	$117.1M
Current ratio	7.27
Net working capital	$-63.7M
Quick ratio	6.82
Working capital	$734.1M

Metric

Value

Current assets

$851.2M

Current liabilities

$117.1M

Current ratio

7.27

Net working capital

$-63.7M

Quick ratio

6.82

Working capital

$734.1M

Metric	Value
Buyback yield / dilution	-21.12%
Dividend yield	0%
Shareholder yield	-21.12%

Metric

Value

Buyback yield / dilution

-21.12%

Dividend yield

Shareholder yield

-21.12%

Metric	Value
150-day SMA	$34.02
1D price change	1.9%
1M price change	-12.4%
1M total return	-12.4%
1W price change	2.03%
1W total return	2.03%
1Y price change	36.12%
1Y return CAGR	36.15%
1Y total return	36.12%
20-day SMA	$29.70
200-day SMA	$32.02
3M price change	-27.24%
3M total return	-27.24%
3Y price change	-12.72%
3Y return CAGR	-4.43%
3Y total return	-12.72%
50-day SMA	$35.16
50-day SMA vs 200-day SMA	50over200
52-week high	$45.42
52-week high date	2026-08-19
52-week low	$21.05
52-week low date	2025-10-28
5Y price change	272.54%
5Y return CAGR	30.09%
5Y total return	272.54%
6M price change	1.92%
6M total return	1.92%
All-time high	$53.75
All-time high date	2020-11-18
All-time low	$3.15
All-time low date	2022-06-13
Average true range (ATR)	$1.22
Average volume	1.4M
Beta (1Y)	1.47
Beta (2Y)	1.3
Beta (5Y)	0.84
Change from 52-week high	-35.2%
Change from 52-week low	39.81%
Change from all-time high	-45.73%
Change from all-time low	827.5%
Change from open	3.55%
Day's gap	-1.59%
Dollar volume	$29.6M
High price	$29.45
Low price	$28.42
Monthly RSI	52.14
Open price	$28.42
Position in 52-week range	98.06%
Premarket change	0.1%
Premarket close	$28.88
Premarket price	$28.91
Premarket volume	1.3K
Previous close	$28.88
Price vs 150-day SMA	-14.26%
Price vs 20-day SMA	-1.79%
Price vs 200-day SMA	-8.89%
Price vs 50-day SMA	-17.04%
Relative volume	0.74
RSI	38.71
Sharpe ratio	0.73
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	0.59
Sortino ratio	1.59
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	1.3
Volume	1M
Weekly RSI	42.31
YTD price change	14.75%
YTD total return	14.75%

Metric

Value

150-day SMA

$34.02

1D price change

1.9%

1M price change

-12.4%

1M total return

-12.4%

1W price change

2.03%

1W total return

2.03%

1Y price change

36.12%

1Y return CAGR

36.15%

1Y total return

36.12%

20-day SMA

$29.70

200-day SMA

$32.02

3M price change

-27.24%

3M total return

-27.24%

3Y price change

-12.72%

3Y return CAGR

-4.43%

3Y total return

-12.72%

50-day SMA

$35.16

50-day SMA vs 200-day SMA

50over200

52-week high

$45.42

52-week high date

2026-08-19

52-week low

$21.05

52-week low date

2025-10-28

5Y price change

272.54%

5Y return CAGR

30.09%

5Y total return

272.54%

6M price change

1.92%

6M total return

1.92%

All-time high

$53.75

All-time high date

2020-11-18

All-time low

$3.15

All-time low date

2022-06-13

Average true range (ATR)

$1.22

Average volume

1.4M

Beta (1Y)

1.47

Beta (2Y)

1.3

Beta (5Y)

0.84

Change from 52-week high

-35.2%

Change from 52-week low

39.81%

Change from all-time high

-45.73%

Change from all-time low

827.5%

Change from open

3.55%

Day's gap

-1.59%

Dollar volume

$29.6M

High price

$29.45

Low price

$28.42

Monthly RSI

52.14

Open price

$28.42

Position in 52-week range

98.06%

Premarket change

0.1%

Premarket close

$28.88

Premarket price

$28.91

Premarket volume

1.3K

Previous close

$28.88

Price vs 150-day SMA

-14.26%

Price vs 20-day SMA

-1.79%

Price vs 200-day SMA

-8.89%

Price vs 50-day SMA

-17.04%

Relative volume

0.74

RSI

38.71

Sharpe ratio

0.73

Sharpe ratio (3Y)

0.1

Sharpe ratio (5Y)

0.59

Sortino ratio

1.59

Sortino ratio (3Y)

0.27

Sortino ratio (5Y)

1.3

Volume

Weekly RSI

42.31

YTD price change

14.75%

YTD total return

14.75%

Metric	Value
Float	91.8M
Float percentage	44.43%
Shares change (QoQ)	0.9%
Shares change (YoY)	21.12%
Shares held by insiders	0.71%
Shares held by institutions	54.76%
Shares outstanding	206.6M
Short % of float	19.91%
Short % of shares	8.85%
Short ratio	11.3 days

Metric

Value

Float

91.8M

Float percentage

44.43%

Shares change (QoQ)

0.9%

Shares change (YoY)

21.12%

Shares held by insiders

0.71%

Shares held by institutions

54.76%

Shares outstanding

206.6M

Short % of float

19.91%

Short % of shares

8.85%

Short ratio

11.3 days

Immunovant, Inc. (IMVT)

Price

Financial snapshot

Fair-value bridge

Latest news · IMVT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMVT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IMVT

Frequently asked questions